SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/20 Nymox Pharmaceutical Corp 20-F 12/31/19 107:5.1M Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size 1: 20-F Annual Report by a Foreign Non-Canadian Issuer HTML 722K 4: EX-13.A Annual or Quarterly Report to Security Holders HTML 25K 5: EX-13.B Annual or Quarterly Report to Security Holders HTML 25K 2: EX-12.A Statement re: Computation of Ratios HTML 30K 3: EX-12.B Statement re: Computation of Ratios HTML 30K 59: R1 Document and Entity Information HTML 54K 92: R2 Consolidated Statements of Comprehensive Income HTML 78K 82: R3 Consolidated Statements of Financial Position HTML 87K 22: R4 Consolidated Statements of Financial Position HTML 28K (Parenthetical) 58: R5 Consolidated Statements of Cash Flow HTML 93K 91: R6 Consolidated Statements of Changes in Equity HTML 73K 81: R7 Business Activities and Basis of Presentation HTML 37K 21: R8 Going Concern Considerations HTML 30K 60: R9 Significant Estimates HTML 28K 97: R10 Significant Accounting Policies HTML 76K 62: R11 New Accounting Standards and Interpretations HTML 30K 27: R12 Property and Equipment HTML 89K 39: R13 Intangible Assets HTML 29K 96: R14 Accounts Payable and Accrued Liabilities HTML 38K 61: R15 Convertible Notes HTML 40K 26: R16 Operating Leases and Commitments HTML 42K 38: R17 Share Capital HTML 41K 95: R18 Stock Options HTML 51K 63: R19 Share Based Compensation HTML 37K 19: R20 Warrants HTML 59K 57: R21 Income Taxes HTML 60K 94: R22 Earnings Per Share HTML 35K 84: R23 Financial Instruments Fair Value Disclosures HTML 29K 18: R24 Finance Income and Finance Costs HTML 52K 56: R25 Segment Disclosures HTML 43K 93: R26 Concentrations HTML 32K 83: R27 Related Party Transactions HTML 39K 20: R28 Research and Development Expenses HTML 40K 55: R29 Personnel Expenses HTML 37K 35: R30 Capital Disclosures and Financial Risk HTML 29K 24: R31 Foreign Exchange Risk HTML 28K 64: R32 Credit Risk HTML 30K 98: R33 Interest Rate Risk HTML 27K 36: R34 Liquidity Risk HTML 33K 25: R35 Subsequent Events HTML 28K 65: R36 Significant Accounting Policies (Policies) HTML 127K 99: R37 Significant Accounting Policies (Tables) HTML 29K 37: R38 Property and Equipment (Tables) HTML 88K 23: R39 Accounts Payable and Accrued Liabilities (Tables) HTML 37K 51: R40 Convertible Notes (Tables) HTML 35K 16: R41 Commitments and Contingencies (Tables) HTML 38K 75: R42 Share Capital (Tables) HTML 36K 85: R43 Stock Options (Tables) HTML 55K 52: R44 Share Based Compensation (Tables) HTML 34K 17: R45 Warrants (Tables) HTML 55K 76: R46 Income Taxes (Tables) HTML 65K 86: R47 Earnings Per Share (Tables) HTML 33K 53: R48 Finance Income and Finance Costs (Tables) HTML 51K 15: R49 Segment Disclosures (Tables) HTML 42K 33: R50 Concentrations (Tables) HTML 31K 47: R51 Related Party Transactions (Tables) HTML 35K 101: R52 Research and Development Expenses (Tables) HTML 39K 68: R53 Personnel Expenses (Tables) HTML 36K 32: R54 Liquidity risk (Tables) HTML 31K 46: R55 Significant Accounting Policies (Details) HTML 33K 100: R56 Significant Accounting Policies (Details HTML 28K Narrative) 67: R57 New Accounting Standards and Interpretations HTML 35K (Details Narrative) 34: R58 Property and Equipment (Details) HTML 60K 45: R59 Property and Equipment (Details Narrative) HTML 28K 90: R60 Intangible Assets (Details Narrative) HTML 38K 79: R61 Accounts Payable and Accrued Liabilities (Details) HTML 34K 14: R62 Convertible Notes (Details) HTML 32K 50: R63 Convertible Notes (Details Narrative) HTML 40K 88: R64 Operating Leases and Commitments (Details) HTML 31K 77: R65 Operating Leases and Commitments (Details 1) HTML 34K 12: R66 Operating Leases and Commitments (Details HTML 40K Narrative) 48: R67 Share Capital (Details) HTML 30K 87: R68 Share Capital (Details Narrative) HTML 40K 80: R69 Stock Options (Details) HTML 52K 71: R70 Stock Options (Details 1) HTML 43K 102: R71 Stock Options (Details Narrative) HTML 30K 41: R72 Share Based Compensation (Details) HTML 34K 28: R73 Share Based Compensation (Details Narrative) HTML 38K 74: R74 Warrants (Details) HTML 48K 105: R75 Warrants (Details Narrative) HTML 36K 44: R76 Income Taxes (Details) HTML 43K 31: R77 Income Taxes (Details 1) HTML 33K 69: R78 Income Taxes (Details 2) HTML 84K 106: R79 Income Taxes (Details Narrative) HTML 28K 72: R80 Earnings Per Share (Details) HTML 31K 103: R81 Financial Instruments Fair Value Disclosures HTML 34K (Details Narrative) 42: R82 Finance Income and Finance Costs (Details) HTML 47K 29: R83 Segment Disclosures (Details) HTML 43K 73: R84 Concentrations (Details) HTML 32K 104: R85 Related Party Transactions (Details) HTML 36K 43: R86 Related Party Transactions (Details Narrative) HTML 36K 30: R87 Research and Development Expenses (Details) HTML 41K 70: R88 Personnel Expenses (Details) HTML 35K 107: R89 Capital Disclosures and Financial Risk (Details HTML 39K Narrative) 89: R90 Foreign Exchange risk (Details Narrative) HTML 28K 78: R91 Credit risk (Details Narrative) HTML 34K 13: R92 Interest rate risk (Details Narrative) HTML 27K 49: R93 Liquidity risk (Details) HTML 35K 66: XML IDEA XML File -- Filing Summary XML 195K 40: EXCEL IDEA Workbook of Financial Reports XLSX 101K 6: EX-101.INS XBRL Instance -- nymx-20191231 XML 1.64M 8: EX-101.CAL XBRL Calculations -- nymx-20191231_cal XML 146K 9: EX-101.DEF XBRL Definitions -- nymx-20191231_def XML 448K 10: EX-101.LAB XBRL Labels -- nymx-20191231_lab XML 907K 11: EX-101.PRE XBRL Presentations -- nymx-20191231_pre XML 735K 7: EX-101.SCH XBRL Schema -- nymx-20191231 XSD 307K 54: ZIP XBRL Zipped Folder -- 0001640334-20-000668-xbrl Zip 133K
|
This ‘20-F’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/30/20 | None on these Dates | ||
For Period end: | 12/31/19 | |||
List all Filings |